Xianan Sang

787 total citations
34 papers, 551 citations indexed

About

Xianan Sang is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Xianan Sang has authored 34 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Xianan Sang's work include Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (4 papers) and Cancer-related molecular mechanisms research (3 papers). Xianan Sang is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Liver physiology and pathology (4 papers) and Cancer-related molecular mechanisms research (3 papers). Xianan Sang collaborates with scholars based in China and Canada. Xianan Sang's co-authors include Gang Cao, Kuilong Wang, Qiyuan Shan, Xin Han, Gang Cao, Xin Wu, Qiao Yang, Dongxin Tang, Li Luo and Bing Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Journal of Chromatography A.

In The Last Decade

Xianan Sang

32 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianan Sang China 13 294 159 95 63 53 34 551
Weiming He China 13 285 1.0× 115 0.7× 63 0.7× 53 0.8× 63 1.2× 46 663
Noha A. El-Boghdady Egypt 16 224 0.8× 141 0.9× 39 0.4× 60 1.0× 47 0.9× 31 591
Yifang Li China 13 207 0.7× 82 0.5× 104 1.1× 60 1.0× 49 0.9× 28 566
Haiyan Sun China 8 242 0.8× 62 0.4× 72 0.8× 54 0.9× 45 0.8× 22 519
Kuilong Wang China 12 241 0.8× 100 0.6× 53 0.6× 88 1.4× 41 0.8× 27 425
Mohamed O. Mahmoud Egypt 13 200 0.7× 86 0.5× 100 1.1× 38 0.6× 31 0.6× 24 575
Junjie Hu China 17 420 1.4× 234 1.5× 140 1.5× 26 0.4× 50 0.9× 56 815
Quan Jin China 19 366 1.2× 65 0.4× 159 1.7× 106 1.7× 40 0.8× 33 694
Jialin Sun China 14 366 1.2× 130 0.8× 37 0.4× 66 1.0× 75 1.4× 46 631
Yiming Zhang China 13 265 0.9× 123 0.8× 36 0.4× 66 1.0× 31 0.6× 41 521

Countries citing papers authored by Xianan Sang

Since Specialization
Citations

This map shows the geographic impact of Xianan Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianan Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianan Sang more than expected).

Fields of papers citing papers by Xianan Sang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianan Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianan Sang. The network helps show where Xianan Sang may publish in the future.

Co-authorship network of co-authors of Xianan Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Xianan Sang. A scholar is included among the top collaborators of Xianan Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianan Sang. Xianan Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lu, Qiang Lyu, Qiyuan Shan, et al.. (2025). Molecular network strategies combined with MCnebula2 identify potential active compounds from steamed Polygonatum cyrtonema Hua. Journal of Chromatography A. 1746. 465779–465779. 1 indexed citations
2.
Ding, Chuan Hun, Sunan Li, Xinyue Dou, et al.. (2025). Taxifolin attenuates liver fibrosis by regulating the phosphorylation of NDRG1 at Thr328 via hepatocyte-stellate cell cross talk. Acta Pharmaceutica Sinica B. 15(4). 2059–2076.
3.
Dou, Xinyue, Zhichao Wang, Chuan Hun Ding, et al.. (2024). SIRT3: A potential therapeutic target for liver fibrosis. Pharmacology & Therapeutics. 257. 108639–108639. 15 indexed citations
4.
Hao, Min, Pingping Wang, Ziyan Chen, et al.. (2024). The role of JNK signaling pathway in organ fibrosis. Journal of Advanced Research. 74. 207–223. 4 indexed citations
5.
Fang, Yuanyuan, Qiao Yang, Mengyun Peng, et al.. (2024). Protective effect of MP-40 mitigates BDL-induced hepatic fibrosis by inhibiting the NLRP3-mediated pyroptosis. Frontiers in Pharmacology. 15. 1479503–1479503. 2 indexed citations
6.
Peng, Mengyun, Hongyan Dong, Chuan Hun Ding, et al.. (2024). Self-heating mitochondrion-induced free radical blast for immunogenic cell death stimulation and HCC immunotherapy. Journal of Controlled Release. 366. 694–711. 3 indexed citations
7.
Ning, Yan, Xinyue Dou, Chuan Hun Ding, et al.. (2024). Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity. Frontiers in Pharmacology. 15. 1370900–1370900. 9 indexed citations
8.
Hao, Min, Xin Han, Han Zhang, et al.. (2022). The pathogenesis of organ fibrosis: Focus on necroptosis. British Journal of Pharmacology. 180(22). 2862–2879. 24 indexed citations
9.
Hao, Min, Mengting Zhao, Ziyan Chen, et al.. (2022). Active ingredients screening and pharmacological mechanism research of curcumae rhizoma-sparganii rhizoma herb pair ameliorates liver fibrosis based on network pharmacology. Journal of Ethnopharmacology. 305. 116111–116111. 10 indexed citations
10.
Sang, Xianan, Xin Han, Qiyuan Shan, et al.. (2022). Screening of Bioactive Fraction of Radix Paeoniae Alba and Enhancing Anti-Allergic Asthma by Stir-Frying Through Regulating PI3K/AKT Signaling Pathway. Frontiers in Pharmacology. 13. 863403–863403. 10 indexed citations
11.
Sang, Xianan, Qiao Yang, Qiyuan Shan, et al.. (2022). The most bioactive fraction of stir-fried Radix Paeoniae Alba regulating IL-6/STAT3 signaling pathway in allergic asthma mouse. Journal of Ethnopharmacology. 301. 115821–115821. 11 indexed citations
12.
Shan, Qiyuan, Xin Han, Hui Hui, et al.. (2022). Toxicity of Tetradium ruticarpum: Subacute Toxicity Assessment and Metabolomic Identification of Relevant Biomarkers. Frontiers in Pharmacology. 13. 803855–803855. 4 indexed citations
13.
Tang, Dongxin, Wei Huang, Yang Zhu, et al.. (2021). Two immune‐enhanced molecular subtypes differ in inflammation, immune checkpoints, mutations, and prognostic outcome in stage I–II colonic carcinoma. Journal of Biochemical and Molecular Toxicology. 35(4). e22703–e22703. 1 indexed citations
14.
Han, Xin, Chuan Hun Ding, Xianan Sang, et al.. (2021). Targeting Sirtuin1 to treat aging-related tissue fibrosis: From prevention to therapy. Pharmacology & Therapeutics. 229. 107983–107983. 46 indexed citations
16.
Wang, Kuilong, Wei Huang, Xianan Sang, et al.. (2020). Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling. Phytomedicine. 68. 153191–153191. 52 indexed citations
17.
Shan, Qiyuan, Xianan Sang, Hui Hui, et al.. (2020). Processing and Polyherbal Formulation of Tetradium ruticarpum (A. Juss.) Hartley: Phytochemistry, Pharmacokinetics, and Toxicity. Frontiers in Pharmacology. 11. 133–133. 29 indexed citations
18.
19.
Tang, Dongxin, Zhu Yang, Li Luo, et al.. (2019). Long noncoding RNA MALAT1 mediates stem cell‐like properties in human colorectal cancer cells by regulating miR‐20b‐5p/Oct4 axis. Journal of Cellular Physiology. 234(11). 20816–20828. 64 indexed citations
20.
Li, Qinglin, et al.. (2019). Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance. The American Journal of Chinese Medicine. 47(1). 177–201. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026